Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer.

Magnetic nanoparticles have been widely investigated for their great potential as mediators of heat for localised hyperthermia therapy. Nanocarriers have also attracted increasing attention due to the possibility of delivering drugs at specific locations, therefore limiting systematic effects. The enhancement of the anti-cancer effect of chemotherapy with application of concurrent hyperthermia was noticed more than thirty years ago. However, combining magnetic nanoparticles with molecules of drugs in the same nanoformulation has only recently emerged as a promising tool for the application of hyperthermia with combined chemotherapy in the treatment of cancer. The main feature of this review is to present the recent advances in the development of multifunctional therapeutic nanosystems incorporating both magnetic nanoparticles and drugs, and their superior efficacy in treating cancer compared to either hyperthermia or chemotherapy as standalone therapies. The principle of magnetic fluid hyperthermia is also presented.

[1]  Janusz Skowronek,et al.  Hyperthermia – description of a method and a review of clinical applications , 2007 .

[2]  I. Puri,et al.  The effects of magnetic nanoparticle properties on magnetic fluid hyperthermia , 2010 .

[3]  J. Overgaard,et al.  Hyperthermia: a potent enhancer of radiotherapy. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  K. Krishnan Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy , 2010, IEEE Transactions on Magnetics.

[5]  C. Grüttner,et al.  Synthesis and functionalisation of magnetic nanoparticles for hyperthermia applications , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[6]  P. Dhagat,et al.  Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells. , 2013, International journal of pharmaceutics.

[7]  Jinwoo Cheon,et al.  Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. , 2009, Angewandte Chemie.

[8]  T. Ryan Energy-based Treatment of Tissue and Assessment VI , 2009 .

[9]  C. Heidelberger,et al.  Selective heat sensitivity of cancer cells. Biochemical and clinical studies , 1967 .

[10]  Manish K Jaiswal,et al.  Dual pH and temperature stimuli-responsive magnetic nanohydrogels for thermo-chemotherapy. , 2014, Journal of Nanoscience and Nanotechnology.

[11]  V. Cabuil,et al.  Iron Oxide Monocrystalline Nanoflowers for Highly Efficient Magnetic Hyperthermia , 2012 .

[12]  Xuesi Chen,et al.  Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs). , 2011, Journal of colloid and interface science.

[13]  Sébastien Lecommandoux,et al.  Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy. , 2011, ACS Nano.

[14]  M. Ward,et al.  Thermoresponsive Polymers for Biomedical Applications , 2011 .

[15]  P Wust,et al.  Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[16]  A. Mediano,et al.  Accurate measurement of the specific absorption rate using a suitable adiabatic magnetothermal setup , 2008 .

[17]  P. Peer,et al.  Correlation of structural and magnetic properties of Fe3O4 nanoparticles with their calorimetric and magnetorheological performance , 2013 .

[18]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Brian P. Timko,et al.  Remotely Triggerable Drug Delivery Systems , 2010, Advanced materials.

[20]  X. An,et al.  Microstructure study of liposomes decorated by hydrophobic magnetic nanoparticles. , 2012, Chemistry and physics of lipids.

[21]  N. Scholler,et al.  Facile immunotargeting of nanoparticles against tumor antigens using site-specific biotinylated antibody fragments. , 2013, Journal of biomedical nanotechnology.

[22]  S. Sahoo,et al.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.

[23]  C. Rinaldi,et al.  Magnetic fluid hyperthermia: Advances, challenges, and opportunity , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[24]  Florence Gazeau,et al.  Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. , 2006, Radiology.

[25]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[26]  A. Hart,et al.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.

[27]  M. Dewhirst,et al.  Hyperthermia mediated liposomal drug delivery , 2006, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[28]  R. T. Gordon,et al.  Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. , 1979, Medical hypotheses.

[29]  Jing Liu,et al.  Stimuli-responsive magnetic nanomicelles as multifunctional heat and cargo delivery vehicles. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[30]  N. D. Thorat,et al.  Surface functionalized LSMO nanoparticles with improved colloidal stability for hyperthermia applications , 2013 .

[31]  L. Gerweck,et al.  Response of cells to hyperthermia under acute and chronic hypoxic conditions. , 1979, Cancer research.

[32]  H. Maeda Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Sunil Kumar,et al.  In vitro evaluation of PEGylated mesoporous MgFe2O4 magnetic nanoassemblies (MMNs) for chemo-thermal therapy. , 2013, Journal of materials chemistry. B.

[34]  K. Hynynen,et al.  Hyperthermia in cancer treatment. , 1990, Investigative radiology.

[35]  Tej B. Shrestha,et al.  Magnetic-Fe/Fe3O4-nanoparticle-bound SN38 as carboxylesterase-cleavable prodrug for the delivery to tumors within monocytes/macrophages , 2012, Beilstein journal of nanotechnology.

[36]  Y. Jeong,et al.  Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. , 2011, Small.

[37]  Yuanyuan Cai,et al.  Methotrexate-conjugated magnetic nanoparticles for thermochemotherapy and magnetic resonance imaging of tumor , 2012, Journal of Nanoparticle Research.

[38]  Jonathan R. McDaniel,et al.  Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[39]  C. Alexander,et al.  Stimuli responsive polymers for biomedical applications. , 2005, Chemical Society reviews.

[40]  L. Meng,et al.  Highly cross-linked and biocompatible polyphosphazene-coated superparamagnetic Fe3O4 nanoparticles for magnetic resonance imaging. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[41]  Rocío Costo,et al.  Study of Heating Efficiency as a Function of Concentration, Size, and Applied Field in γ-Fe2O3 Nanoparticles , 2012 .

[42]  P. Choyke,et al.  Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target? , 2013, Theranostics.

[43]  P. Guardia,et al.  Tuning the Size, the Shape, and the Magnetic Properties of Iron Oxide Nanoparticles , 2011 .

[44]  C. Winterford,et al.  The role of apoptosis in the response of cells and tumours to mild hyperthermia. , 1991, International journal of radiation biology.

[45]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[46]  S. Rybak,et al.  A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity. , 1993, The Journal of biological chemistry.

[47]  I. Andreu,et al.  Accuracy of available methods for quantifying the heat power generation of nanoparticles for magnetic hyperthermia , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[48]  P. Wust,et al.  The cellular and molecular basis of hyperthermia. , 2002, Critical reviews in oncology/hematology.

[49]  E. Gerner,et al.  Heat shock proteins in thermotolerance and other cellular processes. , 1987, Cancer research.

[50]  J. Lepock,et al.  Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage , 2003, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[51]  David Needham,et al.  Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer. , 2011, The open nanomedicine journal.

[52]  J. Hainfeld,et al.  Intravenous magnetic nanoparticle cancer hyperthermia , 2013, International journal of nanomedicine.

[53]  Matthias Zeisberger,et al.  Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia. , 2009, Journal of magnetism and magnetic materials.

[54]  Hui Mao,et al.  Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia. , 2008, Small.

[55]  L. Trahms,et al.  Investigation of Brownian and Néel relaxation in magnetic fluids , 1999 .

[56]  Christian Bergemann,et al.  Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. , 2008, Biomaterials.

[57]  Shyh-Dar Li,et al.  Hyperthermia-induced drug targeting , 2013, Expert opinion on drug delivery.

[58]  Jun Wang,et al.  Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. , 2011, Bioconjugate chemistry.

[59]  Forrest M Kievit,et al.  Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. , 2010, Biomaterials.

[60]  E. Hall,et al.  Interaction of hyperthermia and chemotherapy agents; cell lethality and oncogenic potential. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[61]  Deping Wang,et al.  Preparation and characterization of temperature-responsive magnetic composite particles for multi-modal cancer therapy , 2011, Journal of materials science. Materials in medicine.

[62]  P. Liu,et al.  Redox‐Responsive Molecular Nanoreservoirs for Controlled Intracellular Anticancer Drug Delivery Based on Magnetic Nanoparticles , 2012, Advanced materials.

[63]  R. Issels Hyperthermia adds to chemotherapy. , 2008, European journal of cancer.

[64]  W. Tremel,et al.  Highly water-soluble magnetic iron oxide (Fe3O4) nanoparticles for drug delivery: enhanced in vitro therapeutic efficacy of doxorubicin and MION conjugates. , 2013, Journal of materials chemistry. B.

[65]  I. Robinson,et al.  Size and shape control for water-soluble magnetic cobalt nanoparticles using polymer ligands , 2008 .

[66]  J. Santamaría,et al.  Magnetic nanoparticles for drug delivery , 2007 .

[67]  D. Morton,et al.  Normal tissue and solid tumor effects of hyperthermia in animal models and clinical trials. , 1979, Cancer research.

[68]  Deping Wang,et al.  Synthesis, characterization and in vitro cytotoxicity of self-regulating magnetic implant material for hyperthermia application , 2009 .

[69]  E. Hall,et al.  The oncogenic potential of a combination of hyperthermia and chemotherapy agents. , 1988, British Journal of Cancer.

[70]  M. Kumar,et al.  Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells , 2012, International journal of nanomedicine.

[71]  M. Barati,et al.  New ${\rm T}_{\rm c}$-Tuned Manganese Ferrite-Based Magnetic Implant for Hyperthermia Therapy Application , 2013, IEEE Transactions on Magnetics.

[72]  Yu Zhang,et al.  Size dependence of specific power absorption of Fe3O4 particles in AC magnetic field , 2004 .

[73]  Werner A. Kaiser,et al.  Enhancement of AC-losses of magnetic nanoparticles for heating applications , 2004 .

[74]  S. Dutz,et al.  Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy , 2007 .

[75]  Yu Zhang,et al.  Influence of morphology and surface exchange reaction on magnetic properties of monodisperse magnetite nanoparticles , 2012 .

[76]  Yu Zhou,et al.  A facile concentric-layered magnetic chitosan hydrogel with magnetic field remote stimulated drug release , 2013 .

[77]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[78]  Y. Akao,et al.  The synergistic effects of hyperthermia and anticancer drugs on induction of apoptosis , 2000, Medical Electron Microscopy.

[79]  Cyrille Boyer,et al.  Functional iron oxide magnetic nanoparticles with hyperthermia-induced drug release ability by using a combination of orthogonal click reactions. , 2013, Angewandte Chemie.

[80]  P. Wust,et al.  Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme , 2010, Journal of Neuro-Oncology.

[81]  Y. Yamini,et al.  Magnetic nanoparticles: Synthesis, stabilization, functionalization, characterization, and applications , 2010 .

[82]  Yitao Wang,et al.  Polymeric micelles drug delivery system in oncology. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[83]  Richard C. Willson,et al.  Tuning the Magnetic Properties of Nanoparticles , 2013, International journal of molecular sciences.

[84]  A. Mediano,et al.  New insights into the heating mechanisms and self-regulating abilities of manganite perovskite nanoparticles suitable for magnetic fluid hyperthermia. , 2012, Nanoscale.

[85]  Qiqing Zhang,et al.  Controllable synthesis, magnetic and biocompatible properties of Fe3O4 and α-Fe2O3 nanocrystals , 2012 .

[86]  P Jack Hoopes,et al.  Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[87]  E. D. Hager,et al.  Hyperthermia in Cancer Treatment: A Primer , 2006 .

[88]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[89]  Le Duc Tung,et al.  Synthesis of nanoparticles for biomedical applications , 2010 .

[90]  A. Saxena,et al.  Effect of Onconase on double-stranded RNA in vitro. , 2009, Anticancer research.

[91]  C. Song,et al.  Blood flow in normal tissues and tumors during hyperthermia. , 1980, Journal of the National Cancer Institute.

[92]  Albert Duschl,et al.  Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle , 2013, Journal of Nanobiotechnology.

[93]  J. Otte,et al.  Hyperthermia in cancer therapy , 1988, European Journal of Pediatrics.

[94]  Robert Ivkov,et al.  Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy , 2007 .

[95]  Y. Qu,et al.  The impact of hyperthermic chemotherapy on human gastric cancer cell lines: preliminary results. , 2006, Oncology reports.

[96]  L. Trahms,et al.  Time domain study of Brownian and Néel relaxation in ferrofluids , 1995 .

[97]  A. Jordan,et al.  Clinical applications of magnetic nanoparticles for hyperthermia , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[98]  Z. Yin,et al.  Magnetite nanoparticles as smart carriers to manipulate the cytotoxicity of anticancer drugs: magnetic control and pH-responsive release , 2012 .

[99]  Takashi Nakagawa,et al.  Suitability of commercial colloids for magnetic hyperthermia , 2009 .

[100]  R. E. Rosensweig,et al.  Heating magnetic fluid with alternating magnetic field , 2002 .

[101]  Carlos Rinaldi,et al.  EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. , 2011, ACS nano.

[102]  In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[103]  Peter Wust,et al.  Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. , 2010, The Lancet. Oncology.

[104]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[105]  Domenico Osella,et al.  The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs. , 2008, Journal of inorganic biochemistry.

[106]  D. Chaudhary,et al.  Doxorubicin-conjugated mesoporous magnetic colloidal nanocrystal clusters stabilized by polysaccharide as a smart anticancer drug vehicle. , 2012, Small.

[107]  H. Shokrollahi,et al.  Ferrite-based magnetic nanofluids used in hyperthermia applications , 2012 .

[108]  Xiaoying Ying,et al.  Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging , 2012, International journal of nanomedicine.

[109]  K. Delman,et al.  The role of hyperthermia in optimizing tumor response to regional therapy , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[110]  A. Carvalho,et al.  Synthesis and characterization of magnetoliposomes for MRI contrast enhancement. , 2013, International journal of pharmaceutics.

[111]  S. Salon,et al.  On the measurement technique for specific absorption rate of nanoparticles in an alternating electromagnetic field , 2012 .

[112]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[113]  L. Tiefenauer,et al.  Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. , 1993, Bioconjugate chemistry.

[114]  S. Curley,et al.  Targeted hyperthermia using metal nanoparticles. , 2010, Advanced drug delivery reviews.

[115]  R. Ningthoujam,et al.  Magnetic chitosan nanocomposite for hyperthermia therapy application: Preparation, characterization and in vitro experiments , 2014 .

[116]  Jean-Paul Fortin,et al.  Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles , 2008, European Biophysics Journal.

[117]  P. Wust,et al.  Magnetic Fluid Hyperthermia (MFH) , 1997 .

[118]  M. El-Sayed,et al.  Catalysis with transition metal nanoparticles in colloidal solution: nanoparticle shape dependence and stability. , 2005, The journal of physical chemistry. B.

[119]  J F Gross,et al.  Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. , 1989, International journal of radiation oncology, biology, physics.

[120]  Balachandran Jeyadevan,et al.  Heat dissipation mechanism of magnetite nanoparticles in magnetic fluid hyperthermia , 2009 .

[121]  Nguyen T. K. Thanh,et al.  Magnetic Nanoparticles : From Fabrication to Clinical Applications , 2012 .

[122]  J. Cheon,et al.  Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia. , 2013, Angewandte Chemie.

[123]  T. Ishiguchi,et al.  Combination of chemotherapy and mild hyperthermia enhances the anti-tumor effects of cisplatin and adriamycin in human bladder cancer T24 cells in vitro , 2010 .

[124]  D. Shieh,et al.  In vivo anti-cancer efficacy of magnetite nanocrystal--based system using locoregional hyperthermia combined with 5-fluorouracil chemotherapy. , 2013, Biomaterials.

[125]  Subhra Mohapatra,et al.  Multifunctional Chitosan Magnetic-Graphene (CMG) Nanoparticles: a Theranostic Platform for Tumor-targeted Co-delivery of Drugs, Genes and MRI Contrast Agents. , 2013, Journal of materials chemistry. B.

[126]  Eugene Shi Guang Choo,et al.  Optimization of surface coating on Fe3O4 nanoparticles for high performance magnetic hyperthermia agents , 2012 .

[127]  G. Balendiran,et al.  The role of glutathione in cancer , 2004, Cell biochemistry and function.

[128]  Zhichuan J. Xu,et al.  Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles , 2010, Advanced materials.

[129]  W Hiddemann,et al.  Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. , 2001, European journal of cancer.

[130]  J. Zee,et al.  Heating the patient: a promising approach? , 2002 .

[131]  Guido Kroemer,et al.  Cell death by necrosis: towards a molecular definition. , 2007, Trends in biochemical sciences.

[132]  P. Wust,et al.  Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles , 1999 .

[133]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[134]  S. Banerjee,et al.  Magnetic Nanoparticles Grafted with Cyclodextrin for Hydrophobic Drug Delivery , 2007 .

[135]  H. Maeda,et al.  The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.

[136]  M. Drofenik,et al.  Synthesis and characterization of Mg1+xFe2−2xTixO4 nanoparticles with an adjustable Curie point , 2014 .

[137]  J. Otlewski,et al.  Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles , 2013, International journal of nanomedicine.

[138]  P. Gutin,et al.  Effects of hyperthermia on DNA interstrand crosslinking after treatment with BCNU in 9L rat brain tumor cells. , 1985, Radiation research.

[139]  C. Winterford,et al.  Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.

[140]  R. Banerjee,et al.  In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia. , 2012, Colloids and surfaces. B, Biointerfaces.

[141]  Q. Pankhurst,et al.  Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. , 2010, Biomaterials.

[142]  M. Willingham Cytochemical Methods for the Detection of Apoptosis , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[143]  J. Pérez-Landazábal,et al.  Effect of a SiO2 coating on the magnetic properties of Fe3O4 nanoparticles , 2012, Journal of physics. Condensed matter : an Institute of Physics journal.

[144]  Tej B. Shrestha,et al.  Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model , 2012, International journal of nanomedicine.

[145]  Miqin Zhang,et al.  Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. , 2010, Advanced drug delivery reviews.

[146]  Thomas H. Epps,et al.  Stimuli responsive materials. , 2013, Chemical Society reviews.

[147]  Nguyen T. K. Thanh,et al.  Mechanisms of nucleation and growth of nanoparticles in solution. , 2014, Chemical reviews.

[148]  Jintian Tang,et al.  Magnetic-mediated hyperthermia for cancer treatment: Research progress and clinical trials , 2013 .

[149]  B. Jeyadevan,et al.  Heating efficiency of magnetite particles exposed to AC magnetic field , 2007 .

[150]  D. Siemann,et al.  The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents. , 2011, Cancer treatment reviews.

[151]  N. Thanh,et al.  Functionalisation of nanoparticles for biomedical applications , 2010 .

[152]  K. Murase,et al.  Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages , 2012, International journal of nanomedicine.

[153]  Jia Zhang,et al.  The anti-hepatoma effect of nanosized Mn–Zn ferrite magnetic fluid hyperthermia associated with radiation in vitro and in vivo , 2013, Nanotechnology.

[154]  Q. Pankhurst,et al.  Progress in applications of magnetic nanoparticles in biomedicine , 2009 .

[155]  R. Ningthoujam,et al.  Functionalization of La(0.7)Sr(0.3)MnO3 nanoparticles with polymer: studies on enhanced hyperthermia and biocompatibility properties for biomedical applications. , 2013, Colloids and surfaces. B, Biointerfaces.

[156]  J. Bacri,et al.  Magnetically induced hyperthermia: size-dependent heating power of γ-Fe2O3 nanoparticles , 2008, Journal of physics. Condensed matter : an Institute of Physics journal.

[157]  V. Pillay,et al.  Stimuli-responsive polymers and their applications in drug delivery , 2009, Biomedical materials.

[158]  C. Kumar,et al.  Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. , 2011, Advanced drug delivery reviews.

[159]  Sarika Singh,et al.  pH‐Responsive Peptide Mimic Shell Cross‐Linked Magnetic Nanocarriers for Combination Therapy , 2012 .

[160]  R. Issels,et al.  Hyperthermia in oncology. , 2001 .

[161]  T. Porter,et al.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[162]  Dexin Sun,et al.  Dendrimer functionalized water soluble magnetic iron oxide conjugates as dual imaging probe for tumor targeting and drug delivery , 2013 .

[163]  Cordelia Selomulya,et al.  Particle size dependence of heating power in MgFe2O4 nanoparticles for hyperthermia therapy application , 2014 .

[164]  T. Sau,et al.  "Complex-shaped Metal Nanoparticles: Bottom-Up Syntheses and Applications" , 2012 .

[165]  C. Ling,et al.  Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[166]  Y. Nishimura,et al.  For the clinical application of thermochemotherapy given at mild temperatures. , 1999, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[167]  Peter Wust,et al.  Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme , 2006, Journal of Neuro-Oncology.

[168]  M. Fujimura,et al.  Antitumor effects of inductive hyperthermia using magnetic ferucarbotran nanoparticles on human lung cancer xenografts in nude mice , 2013, OncoTargets and therapy.

[169]  A. Mohammed,et al.  Trigger release liposome systems: local and remote controlled delivery? , 2012, Journal of microencapsulation.

[170]  Hua Wei,et al.  Design and development of polymeric micelles with cleavable links for intracellular drug delivery , 2013 .

[171]  Y. Haik,et al.  Ni1‐x Crx alloy for self controlled magnetic hyperthermia , 2009 .

[172]  Yasuhiko Yoshida,et al.  Curcumin and 5-Fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia , 2014, International journal of nanomedicine.

[173]  K. Sugimachi,et al.  Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[174]  Tina Hernandez-Boussard,et al.  Doxorubicin pathways: pharmacodynamics and adverse effects , 2011, Pharmacogenetics and genomics.

[175]  H. Gu,et al.  Effects of hyperthermia with dextran magnetic fluid on the growth of grafted H22 tumor in mice , 2009, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[176]  M. McHenry,et al.  Evaluation of iron-cobalt/ferrite core-shell nanoparticles for cancer thermotherapy , 2008 .

[177]  S. Ryu,et al.  Aptamer-conjugated magnetic nanoparticles enable efficient targeted detection of integrin αvβ3 via magnetic resonance imaging. , 2014, Journal of biomedical materials research. Part A.

[178]  Robert J. Griffin,et al.  Improvement of Tumor Oxygenation by Mild Hyperthermia , 2001, Radiation research.

[179]  P. Chandrasekharan,et al.  Facile synthesis of water-stable magnetite nanoparticles for clinical MRI and magnetic hyperthermia applications. , 2010, Nanomedicine.

[180]  P. Wust,et al.  Hyperthermia in combined treatment of cancer. , 2002, The Lancet Oncology.

[181]  W. Hennink,et al.  Thermosensitive polymeric micelles for targeted drug delivery. , 2011, Nanomedicine.

[182]  Yang Xu,et al.  Radio-frequency induced in vitro thermal ablation of cancer cells by EGF functionalized carbon-coated magnetic nanoparticles , 2011 .

[183]  Jie Ren,et al.  Magnetocaloric effect in magnetothermally-responsive nanocarriers for hyperthermia-triggered drug release , 2012, Nanotechnology.

[184]  Yulei Chang,et al.  Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery , 2012 .

[185]  P. Chow,et al.  Thermoresponsive core–shell magnetic nanoparticles for combined modalities of cancer therapy , 2009, Nanotechnology.

[186]  X. An,et al.  Controllable release from magnetoliposomes by magnetic stimulation and thermal stimulation. , 2013, Colloids and surfaces. B, Biointerfaces.

[187]  Hiroyuki Honda,et al.  Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. , 2003, Journal of bioscience and bioengineering.

[188]  Karen L Wooley,et al.  Design of polymeric nanoparticles for biomedical delivery applications. , 2012, Chemical Society reviews.

[189]  R C Miller,et al.  Clinical hyperthermia: Results of a phase I trial employing hyperthermia alone or in combination with external beam or interstitial radiotherapy , 1982, Cancer.

[190]  Brian C. Benicewicz,et al.  Nanocomposites with Polymer Grafted Nanoparticles , 2013 .